Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SURG Stock Summary
Top 10 Correlated ETFs
SURG
In the News
SURG Financial details
Company Rating
Strong Buy
Market Cap
76.39M
Income
20.62M
Revenue
137.14M
Book val./share
1.96
Cash/share
1.02
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
5.32
Forward P/E
-
PEG
-0
P/S
0.78
P/B
4.64
P/C
3.66
P/FCF
8.82
Quick Ratio
1.55
Current Ratio
2.57
Debt / Equity
0.18
LT Debt / Equity
0.02
-
-
EPS (TTM)
1.45
EPS next Y
-
EPS next Q
-
EPS this Y
-12183.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
39.73%
Revenue Q/Q
-5.39%
EPS Q/Q
-58%
-
-
-
-
SMA20
-19.79%
SMA50
-47.43%
SMA100
-34.73%
Inst Own
10.92%
Inst Trans
0.66%
ROA
48%
ROE
150%
ROC
0.75%
Gross Margin
25%
Oper. Margin
15%
Profit Margin
15%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.654-9.23
52W High
-58.56%
52W Low
+24.33%
RSI
36.33
Rel Volume
0.13
Avg Volume
858.11K
Volume
113.01K
Perf Week
-5.57%
Perf Month
-46.79%
Perf Quarter
-15.61%
Perf Half Y
-24.49%
-
-
-
-
Beta
1.479
-
-
Volatility
0.17%, 0.91%
Prev Close
-0.8%
Price
3.73
Change
1.91%
SURG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.38 | 25.49 | 11.65 | 9.81 | 9.62 | |
Net income per share | -4.27 | -7.92 | -4.29 | -0.01 | 1.45 | |
Operating cash flow per share | -3.4 | -2.03 | -3.49 | 0.06 | 0.72 | |
Free cash flow per share | -3.51 | -2.03 | -3.5 | 0.01 | 0.7 | |
Cash per share | 0.18 | 0.32 | 1.43 | 0.57 | 1.03 | |
Book value per share | -2.44 | -5.03 | 0.81 | 0.4 | 1.98 | |
Tangible book value per share | -5.37 | -7.36 | -0.17 | 0.02 | 1.69 | |
Share holders equity per share | -2.44 | -5.03 | 0.81 | 0.4 | 1.98 | |
Interest debt per share | 4.54 | 5.18 | 3.47 | 0.81 | 0.4 | |
Market cap | 28.86M | 12.55M | 8.85M | 81.31M | 91.97M | |
Enterprise value | 37.01M | 19.55M | 10.25M | 82.39M | 82.79M | |
P/E ratio | -3.51 | -0.74 | -0.47 | -546.27 | 4.46 | |
Price to sales ratio | 1.12 | 0.23 | 0.17 | 0.67 | 0.67 | |
POCF ratio | -4.42 | -2.9 | -0.58 | 102.5 | 8.94 | |
PFCF ratio | -4.27 | -2.9 | -0.58 | 858.73 | 9.19 | |
P/B Ratio | -6.14 | -1.17 | 2.49 | 16.29 | 3.26 | |
PTB ratio | -6.14 | -1.17 | 2.49 | 16.29 | 3.26 | |
EV to sales | 1.44 | 0.36 | 0.2 | 0.68 | 0.6 | |
Enterprise value over EBITDA | -5.32 | -4.62 | -1.4 | 44.24 | 4.14 | |
EV to operating cash flow | -5.67 | -4.52 | -0.67 | 103.86 | 8.05 | |
EV to free cash flow | -5.47 | -4.51 | -0.67 | 870.09 | 8.27 | |
Earnings yield | -0.28 | -1.35 | -2.12 | 0 | 0.22 | |
Free cash flow yield | -0.23 | -0.35 | -1.73 | 0 | 0.11 | |
Debt to equity | -1.81 | -0.71 | 2.16 | 1.63 | 0.18 | |
Debt to assets | 0.85 | 1.05 | 0.39 | 0.24 | 0.12 | |
Net debt to EBITDA | -1.17 | -1.65 | -0.19 | 0.58 | -0.46 | |
Current ratio | 0.51 | 0.08 | 1.39 | 1.17 | 2.63 | |
Interest coverage | -29.88 | -2.48 | -0.8 | 0.45 | 31.65 | |
Income quality | 0.77 | 0.4 | 1.13 | -1.43 | 0.5 | |
Dividend Yield | 0 | 0.4 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.3 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.42 | 0.17 | 0.21 | 0.1 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.56 | 0.68 | 0.22 | 0.14 | 0.1 | |
Capex to operating cash flow | 0.03 | 0 | 0 | -0.88 | -0.03 | |
Capex to revenue | -0.01 | 0 | 0 | -0.01 | 0 | |
Capex to depreciation | -0.8 | 0 | -0.06 | -0.71 | -0.25 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 15.32 | 29.92 | 8.84 | 0.33 | 8.03 | |
ROIC | -1.64 | 4.92 | -0.71 | 0.02 | 0.63 | |
Return on tangible assets | -1.89 | -7.25 | -1.24 | -0.01 | 0.55 | |
Graham Net | -44.88K | -7.96 | -1.15 | -0.75 | 0.88 | |
Working capital | -3.48M | -14.05M | 3.89M | 4.1M | 20.66M | |
Tangible asset value | -10.34M | -15.72M | -748.95K | 284.31K | 24.07M | |
Net current asset value | -11.11M | -16.8M | -2.06M | -1.32M | 19.62M | |
Invested capital | -1.81 | -0.71 | 2.16 | 1.63 | 0.18 | |
Average receivables | 2.19M | 1.76M | 1.82M | 6.24M | 9.38M | |
Average payables | 3.95M | 5.99M | 7.67M | 7.75M | 7.5M | |
Average inventory | -86.32B | -86.32B | 2.27M | 7.77M | 10.12M | |
Days sales outstanding | 44.41 | 2.64 | 23.23 | 27.72 | 25.38 | |
Days payables outstanding | 83.34 | 51.61 | 64.99 | 25.37 | 26.65 | |
Days of inventory on hand | -3.1M | 1.25 | 35.44 | 37.78 | 32.19 | |
Receivables turnover | 8.22 | 138.4 | 15.71 | 13.17 | 14.38 | |
Payables turnover | 4.38 | 7.07 | 5.62 | 14.38 | 13.7 | |
Inventory turnover | 0 | 291.28 | 10.3 | 9.66 | 11.34 | |
ROE | 1.75 | 1.58 | -5.29 | -0.03 | 0.73 | |
Capex per share | -0.12 | 0 | -0.01 | -0.06 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.57 | 2.46 | 2.53 | 2.39 | 2.24 | |
Net income per share | 0.22 | 0.32 | 0.42 | 0.5 | 0.21 | |
Operating cash flow per share | 0.34 | 0.2 | -0.19 | 0.57 | 0.14 | |
Free cash flow per share | 0.31 | 0.19 | -0.19 | 0.57 | 0.14 | |
Cash per share | 0.5 | 0.63 | 0.37 | 0.89 | 1.02 | |
Book value per share | 0.35 | 0.7 | 1.15 | 1.66 | 1.96 | |
Tangible book value per share | 0.02 | 0.37 | 0.83 | 1.35 | 1.67 | |
Share holders equity per share | 0.35 | 0.7 | 1.15 | 1.66 | 1.96 | |
Interest debt per share | 0.61 | 0.52 | 0.44 | 0.4 | 0.36 | |
Market cap | 92.61M | 63.45M | 103.74M | 66.88M | 92.9M | |
Enterprise value | 93.68M | 61.81M | 104.64M | 59.67M | 83.72M | |
P/E ratio | 7.6 | 3.49 | 4.35 | 2.36 | 7.69 | |
Price to sales ratio | 2.56 | 1.82 | 2.89 | 1.96 | 2.87 | |
POCF ratio | 19.52 | 22.14 | -39.27 | 8.25 | 47.46 | |
PFCF ratio | 21.26 | 23.42 | -37.5 | 8.25 | 47.46 | |
P/B Ratio | 18.56 | 6.44 | 6.35 | 2.82 | 3.29 | |
PTB ratio | 18.56 | 6.44 | 6.35 | 2.82 | 3.29 | |
EV to sales | 2.59 | 1.78 | 2.92 | 1.75 | 2.59 | |
Enterprise value over EBITDA | 22.82 | 12.32 | 16.12 | 8.04 | 73.23 | |
EV to operating cash flow | 19.75 | 21.57 | -39.61 | 7.36 | 42.77 | |
EV to free cash flow | 21.51 | 22.82 | -37.83 | 7.36 | 42.77 | |
Earnings yield | 0.03 | 0.07 | 0.06 | 0.11 | 0.03 | |
Free cash flow yield | 0.05 | 0.04 | -0.03 | 0.12 | 0.02 | |
Debt to equity | 1.63 | 0.73 | 0.37 | 0.23 | 0.18 | |
Debt to assets | 0.24 | 0.18 | 0.15 | 0.13 | 0.12 | |
Net debt to EBITDA | 0.26 | -0.33 | 0.14 | -0.97 | -8.03 | |
Current ratio | 1.17 | 1.33 | 1.83 | 2.57 | 2.63 | |
Interest coverage | 7.18 | 24.46 | 39.69 | 54.41 | 7.4 | |
Income quality | 1.42 | 0.63 | -0.44 | 1.16 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.08 | 0.08 | 0.1 | 0.09 | 0.19 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.14 | 0.12 | 0.12 | 0.1 | 0.1 | |
Capex to operating cash flow | -0.08 | -0.05 | 0.05 | 0 | 0 | |
Capex to revenue | -0.01 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -1.39 | -0.57 | -0.45 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.01 | -0.01 | 0 | 0.02 | |
Graham number | 1.31 | 2.25 | 3.3 | 4.3 | 3.04 | |
ROIC | 0.24 | 0.25 | 0.26 | 0.24 | 0.1 | |
Return on tangible assets | 0.1 | 0.13 | 0.17 | 0.18 | 0.08 | |
Graham Net | -0.66 | -0.48 | -0.1 | 0.56 | 0.87 | |
Working capital | 4.1M | 8.57M | 15.26M | 22.77M | 20.66M | |
Tangible asset value | 284.31K | 5.19M | 11.84M | 19.32M | 24.07M | |
Net current asset value | -1.32M | 3.63M | 10.35M | 17.86M | 19.62M | |
Invested capital | 1.63 | 0.73 | 0.37 | 0.23 | 0.18 | |
Average receivables | 9.35M | 9.44M | 9.97M | 10.03M | 9.66M | |
Average payables | 12.37M | 7.56M | 6.75M | 6.86M | 7.66M | |
Average inventory | 10.34M | 13.35M | 16.8M | 16.32M | 11.8M | |
Days sales outstanding | 22.93 | 25 | 25.8 | 25.75 | 26.56 | |
Days payables outstanding | 22.92 | 25.29 | 20.5 | 29.78 | 26.8 | |
Days of inventory on hand | 34.12 | 51.58 | 62.95 | 55.3 | 32.38 | |
Receivables turnover | 3.92 | 3.6 | 3.49 | 3.49 | 3.39 | |
Payables turnover | 3.93 | 3.56 | 4.39 | 3.02 | 3.36 | |
Inventory turnover | 2.64 | 1.74 | 1.43 | 1.63 | 2.78 | |
ROE | 0.61 | 0.46 | 0.36 | 0.3 | 0.11 | |
Capex per share | -0.03 | -0.01 | -0.01 | 0 | 0 |
SURG Frequently Asked Questions
What is SurgePays, Inc. stock symbol ?
SurgePays, Inc. is a US stock , located in Bartlett of Tn and trading under the symbol SURG
What is SurgePays, Inc. stock quote today ?
SurgePays, Inc. stock price is $3.73 today.
Is SurgePays, Inc. stock public?
Yes, SurgePays, Inc. is a publicly traded company.